RE: MMs in control23 Nov 2021 09:23
PI100 I can't agree that last week was 'false rises'. This share is stupidly oversold when you look at its's IP assets, the cash on the bank, the pipeline of products, the trade show activity, the bio-informatics service, the non-covid opportunities and the current situation.
I think one of the issues is that we have a low profile in France. For whatever reasons we have not sold much into that market and that is where two thirds of our share-holders live. It will take news to shift this, a resolution of the dispute, RNS updates etc. The problem for a lot of frustrated share-holders is that you can't release news until you have got some to release.
Patience required GLA